These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 11823129

  • 1. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
    Zhang MR, Haradahira T, Maeda J, Okauchi T, Kawabe K, Noguchi J, Kida T, Suzuki K, Suhara T.
    Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
    [Abstract] [Full Text] [Related]

  • 2. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.
    Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
    [Abstract] [Full Text] [Related]

  • 3. Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomography.
    Langer O, Halldin C, Chou Y, Sandell J, Swahn C, Någren K, Perrone R, Berardi F, Leopoldo M, Farde L.
    Nucl Med Biol; 2000 Nov; 27(8):707-14. PubMed ID: 11150701
    [Abstract] [Full Text] [Related]

  • 4. Imaging dopamine D4 receptors in the living primate brain: a positron emission tomography study using the novel D1/D4 antagonist [11C]SDZ GLC 756.
    Boy C, Klimke A, Holschbach M, Herzog H, Mühlensiepen H, Rota Kops E, Sonnenberg F, Gaebel W, Stöcklin G, Markstein R, Müller-Gärtner HW.
    Synapse; 1998 Dec; 30(4):341-50. PubMed ID: 9826226
    [Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents.
    Leopoldo M, Selivanova SV, Müller A, Lacivita E, Schetz JA, Ametamey SM.
    Chem Biodivers; 2014 Sep; 11(9):1298-308. PubMed ID: 25238073
    [Abstract] [Full Text] [Related]

  • 6. N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide: a potent and selective dopamine D4 ligand.
    Perrone R, Berardi F, Colabufo NA, Leopoldo M, Tortorella V.
    J Med Chem; 1998 Nov 19; 41(24):4903-9. PubMed ID: 9822559
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.
    Lacivita E, De Giorgio P, Lee IT, Rodeheaver SI, Weiss BA, Fracasso C, Caccia S, Berardi F, Perrone R, Zhang MR, Maeda J, Higuchi M, Suhara T, Schetz JA, Leopoldo M.
    J Med Chem; 2010 Oct 28; 53(20):7344-55. PubMed ID: 20873719
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma(1) receptors.
    Zhang MR, Haradahira T, Maeda J, Okauchi T, Kawabe K, Kida T, Obayashi S, Suzuki K, Suhara T.
    Nucl Med Biol; 2002 May 28; 29(4):469-76. PubMed ID: 12031882
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, lipophilic properties, and binding affinities of potential ligands in positron emission tomography (PET) for visualization of brain dopamine D4 receptors.
    Lacivita E, De Giorgio P, Colabufo NA, Berardi F, Perrone R, Niso M, Leopoldo M.
    Chem Biodivers; 2014 Feb 28; 11(2):299-310. PubMed ID: 24591318
    [Abstract] [Full Text] [Related]

  • 10. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW, Halldin C, McCarron JA, Lundkvist C, Hirani E, Olsson H, Hume SP, Karlsson P, Osman S, Swahn CG, Hall H, Wikström H, Mensonidas M, Poole KG, Farde L.
    Eur J Nucl Med; 1998 Apr 28; 25(4):338-46. PubMed ID: 9553162
    [Abstract] [Full Text] [Related]

  • 11. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW.
    J Pharmacol Exp Ther; 1997 Aug 28; 282(2):1020-7. PubMed ID: 9262371
    [Abstract] [Full Text] [Related]

  • 12.
    Leung K.
    ; 2004 Aug 28. PubMed ID: 23785734
    [Abstract] [Full Text] [Related]

  • 13. Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors.
    Langer O, Halldin C, Dollé F, Swahn CG, Olsson H, Karlsson P, Hall H, Sandell J, Lundkvist C, Vaufrey F, Loc'h C, Crouzel C, Mazière B, Farde L.
    Nucl Med Biol; 1999 Jul 28; 26(5):509-18. PubMed ID: 10473189
    [Abstract] [Full Text] [Related]

  • 14. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 28; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.
    Ohmori J, Maeno K, Hidaka K, Nakato K, Matsumoto M, Tada S, Hattori H, Sakamoto S, Tsukamoto S, Usuda S, Mase T.
    J Med Chem; 1996 Jul 05; 39(14):2764-72. PubMed ID: 8709107
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomographic evaluation of the putative dopamine-D3 receptor ligand, [11C]RGH-1756 in the monkey brain.
    Sóvágó J, Farde L, Halldin C, Langer O, Laszlovszky I, Kiss B, Gulyás B.
    Neurochem Int; 2004 Oct 05; 45(5):609-17. PubMed ID: 15234102
    [Abstract] [Full Text] [Related]

  • 17. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ.
    Neuroscience; 1998 Mar 05; 83(1):169-76. PubMed ID: 9466407
    [Abstract] [Full Text] [Related]

  • 18. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J, Halldin C, Pike VW, Chou YH, Varnäs K, Hall H, Marchais S, Nowicki B, Wikström HV, Swahn CG, Farde L.
    Nucl Med Biol; 2001 Feb 05; 28(2):177-85. PubMed ID: 11295428
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
    Noda-Saita K, Matsumoto M, Hidaka K, Hatanaka K, Ohmori J, Okada M, Yamaguchi T.
    Biochem Biophys Res Commun; 1999 Feb 16; 255(2):367-70. PubMed ID: 10049714
    [Abstract] [Full Text] [Related]

  • 20. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, Terranova MA, Donnelly-Roberts DL, Namovic MT, Miller TR, Wetter JM, Marsh K, Stewart AO, Brioni JD, Moreland RB.
    Neuropharmacology; 2005 Jul 16; 49(1):112-21. PubMed ID: 15992586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.